Divisiveness brings uncertainty

Carlson, Joe; Blesch, Gregg; Barr, Paul
August 2011
Modern Healthcare;8/1/2011, Vol. 41 Issue 31, p8
Trade Publication
The article reports that U.S. District Judge Royce Lamberth has ruled in favor of Obama administration's continuous support of embryonic stem-cell research. In 2010, Lamberth froze the research funding after U.S. President Barack Obama lifted a ban on all research conducted by the U.S. National Institutes of Health (NIH). Susan Solomon, New York Stem Cell Foundation chief executive officer (CEO), comments on the effect of constant political fights on research funding.


Related Articles

  • Can US Congress overturn stem-cell funding freeze? Aldhouse, Peter // New Scientist;9/4/2010, Vol. 207 Issue 2776, p1 

    The author opines regarding the U.S. Dickey Wicker amendment that freezes federal financing of human embryonic stem cell (hESC) research and actions that the U.S. Congress could take to amend the law.

  • Stop-and-go scenario: Researchers say lawsuit over stem-cell funding hinders progress on treatments. Barr, Paul // Modern Healthcare;3/21/2011, Vol. 41 Issue 12, p48 

    The article discusses the reactions of U.S. researchers on the legal battle over federal funding of human embryonic stem-cell research in the case James L. Sherley v. Kathleen Sebelius. According to Clive Svendsen, director of the Regenerative Medicine Institute at Cedars-Sinai Medical Center in...

  • NIH embryo policy draws bilateral fire.  // Medical Device Daily;4/21/2009, Vol. 13 Issue 75, p4 

    The article reports on a draft guideline published by the U.S. National Institutes of Health for dealing with the use of embryos as a source of stem cells. According to the guideline, NIH would restrict embryo use to those created for reproductive purposes but have not been used and scheduled...

  • Under starter's orders. Boyce, Nell // New Scientist;09/02/2000, Vol. 167 Issue 2254, p6 

    Reports on the development of research using human embryos. Guidelines set by the United States National Institutes of Health which will allow researchers to apply for public funds to work with embryonic stem cells; Differences between British and American laws concerning stem cell research.

  • US labs bemoan lack of stem cells. Powell, Kendall // Nature;7/25/2002, Vol. 418 Issue 6896, p358 

    Reports on the constraint on the availability of human embryonic stem cells in the U.S. as of July 2002. Number of eligible cell lines that were identified by National Institutes of Health (NIH); Hurdles faced by researchers in obtaining lines that the NIH regards as available; Action done by...

  • INFORMED CONSENT and FEDERAL FUNDING for STEM CELL RESEARCH. Streiffer, Robert // Hastings Center Report;May/Jun2008, Vol. 38 Issue 3, p40 

    The article discusses a review of the consent forms signed by those who donated embryos for the U.S. National Institutes of Health (NIH)-approved embryonic stem cell lines which reveals several problems, providing ethical as well as scientific reasons to overturn the U.S. government's...

  • In Support of Stem Cells. Lemonick, Michael D.; Thompson, Dick // Time;9/4/2000, Vol. 156 Issue 10, p58 

    Reports that under guidelines issued by the United States National Institutes of Health, government-funded scientists can use early-stage embryos left over from in-vitro fertilizations for research. Requirement that harvesting must be done by private firms; Potential of embryonic stem cells for...

  • NIH implements order to expand lines of pluripotent stem cells.  // Medical Device Daily;9/24/2007, Vol. 11 Issue 182, p2 

    The article reports that the U.S. National Institutes of Health (NIH) will begin implementing the executive order of U.S. President George W. Bush to explore methods to expand the number of approved pluripotent stem cell lines without creating a human embryo for research purposes or destroying,...

  • APPENDIX C. Bailey, Ronald // Human Life Review;Fall2005, Vol. 30 Issue 1, p85 

    The article presents a reprint of the article “No Shortage of Funds,” by Ronald Bailey, which appeared in the 2005 issue of “Wall Street Journal.” It focuses on the funding of human embryonic stem-cell research in the public and private sectors. The U.S. National...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics